Henry Schein Medical Announces Expansion of Medpod’s Telemedicine Solutions With Integration of VisualDx

July 9, 2020

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. and exclusive distributor of Medpod, Inc.’s telemedicine solutions, announced today the integration of VisualDx – a clinical decision support system – with Medpod’s technology infrastructure to help health care professionals better diagnose patients virtually.

Henry Schein notes VisualDx is designed to enhance diagnostic accuracy, aid therapeutic decisions, and improve patient care, all critically important to health care professionals on the front lines of medicine.

“Henry Schein Medical is pleased to announce the expansion and enhancement of the Medpod platform for our customers. With many clinicians moving to a virtual care model, it’s imperative that they are equipped with decision-support technology to aid in diagnostic and therapeutic decisions,” said Todd Stack, Senior Director, Henry Schein Medical, who manages the exclusive relationship with Medpod. “With Medpod, our customers can engage with patients remotely to reduce exposure, and monitor at risk and symptomatic patients remotely, which benefits both the patient and practice.”

Medpod’s cloud-based software and modular infrastructure gives providers and operators the ability to deliver customizable, high-quality, and convenient care that meets the needs of patients who cannot visit a traditional office setting. With the integration of VisualDx’s clinical support, Medpod users can access a database of information written by a variety of medical experts; recognize disease variants; identify drug adverse events; and enhance patient education to help provide informed, accurate, and fast decision-making. The platform also assists users to make custom diagnoses as a result of having the ability to enter patient-specific information, such as age range, gender, symptoms and signs; search by disease for quick therapy and treatment options; review and compare a curated medical image library; enhance understanding of medication reactions; and share patient handouts via email. Clinicians can also earn Continuing Medical Education (CME) credits each time they use VisualDx as part of their subscription.

Available as one of Henry Schein Medical’s SolutionHub™ clinical support solutions, VisualDx can support common and complex diagnostic cases across medicine including rashes, variant presentations of symptoms, and emerging infectious diseases. The software is relevant for a range of health care specialties, including: Family Medicine, Internal Medicine, Urgent Care, Infectious Disease, Dermatology, Emergency Medicine, Pediatrics, Risk Management, and Medical Education.

“We are excited to continue to enhance our relationship with Henry Schein by offering this telemedicine integration to help aid clinician decisions, drive quality care, and enhance diagnostic and therapy decisions during the telemedicine encounter,” said Art Papier, MD, CEO of VisualDx.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version